Literature DB >> 6086517

Erythrocyte Na+,K+ cotransport and Na+,K+ pump in black and caucasian hypertensive patients.

M L Tuck, C Gross, M H Maxwell, A S Brickman, G Krasnoshtein, D Mayes.   

Abstract

Alterations in red blood cell (RBC) Na+,K+ pump and in Na+,K+ cotransport (CoT) have been described in essential hypertension (EH). We examined pump and CoT in 50 normotensive (NT) subjects and 58 EH subjects subdivided by race and family history of hypertension (+ FH). RBCs were preloaded with Na+ to obtain intracellular levels of 25 mM/liter cells by using the p-chloromercuribenzene sulfonic acid (pCMBS) method. Na+ and K+ efflux rates into a magnesium-sucrose medium were quantitated in the presence of ouabain and ouabain plus furosemide to define pump and CoT activity respectively. Mean intracellular Na+ content was higher (p less than 0.05) in black NT and HT subjects compared to Caucasians. Mean RBC CoT was lower in black EH compared to NT and compared to Caucasian NT and HT subjects. Conversely, Caucasian HT patients had higher mean CoT than NT subjects. Subdivision into + FH revealed very little effect of + FH on CoT in black NT and HT subjects. In Caucasian NT and HT subjects with + FH, mean CoT was significantly reduced (less than 0.3 mM/liter cells/hr) compared to those without + FH. A subgroup of Caucasian EH subjects displayed high CoT (greater than 0.6 mM/liter cells/hr); a + FH had little impact on the high CoT group. There was no correlation between RBC CoT activity and age, sex, severity of hypertension, urinary sodium excretion, and plasma aldosterone. There was a positive correlation (r = + 0.47; p less than 0.01) between CoT and upright plasma renin activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6086517     DOI: 10.1161/01.hyp.6.4.536

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

Review 1.  Essential hypertension in blacks: epidemiology, characteristics, and possible roles of racial differences in sodium, potassium, and calcium regulation.

Authors:  A Aviv; M Aladjem
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

2.  Black/white differences in response to antihypertensive therapy.

Authors:  B J Materson
Journal:  J Natl Med Assoc       Date:  1985-05       Impact factor: 1.798

3.  Race and sex differences in erythrocyte Na+, K+, and Na+-K+-adenosine triphosphatase.

Authors:  N Lasker; L Hopp; S Grossman; R Bamforth; A Aviv
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

4.  Changes in sodium-lithium countertransport correlate with changes in triglyceride levels and body mass index over 2 1/2 years of follow-up in Utah.

Authors:  S C Hunt; R R Williams; K O Ash
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

Review 5.  Erythrocyte concentrations and transmembrane fluxes of sodium and potassium in essential hypertension: role of intrinsic and environmental factors.

Authors:  P Lijnen; J R M'Buyamba-Kabangu; R Fagard; J Staessen; A Amery
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

Review 6.  Alterations in sodium metabolism as an etiological model for hypertension.

Authors:  P Lijnen
Journal:  Cardiovasc Drugs Ther       Date:  1995-06       Impact factor: 3.727

7.  Decreased NKCC1 activity in erythrocytes from African Americans with hypertension and dyslipidemia.

Authors:  Sergei N Orlov; Francis Gossard; Zdenka Pausova; Olga A Akimova; Johanne Tremblay; Clarence E Grim; Jane M Kotchen; Theodore A Kotchen; Daniel Gaudet; Allen W Cowley; Pavel Hamet
Journal:  Am J Hypertens       Date:  2009-12-31       Impact factor: 2.689

8.  NKCC1 and NKCC2: The pathogenetic role of cation-chloride cotransporters in hypertension.

Authors:  Sergei N Orlov; Svetlana V Koltsova; Leonid V Kapilevich; Svetlana V Gusakova; Nickolai O Dulin
Journal:  Genes Dis       Date:  2015-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.